Table 2.
unique peptide No. | expression in cancer cases |
frequency* | |||||
---|---|---|---|---|---|---|---|
protein ID | protein name | p-value (FDR) | non-cancer | cancer | non-cancer | cancer | |
P01009 | Alpha-1-antitrypsin | < 0.01 | 20 | 20 | up | 0.87 | 0.98 |
P02787 | Serotransferrin | 0.04 | 20 | 25 | up | 0.62 | 0.91 |
P02790 | Hemopexin | 0.02 | 14 | 20 | up | 0.81 | 0.96 |
P07602 | Proactivator polypeptide | < 0.01 | 7 | 6 | down | 0.6 | 0.34 |
P07911 | Uromodulin | 0.08 | 19 | 16 | down | 0.91 | 0.7 |
P10451 | Osteopontin | 0.06 | 4 | 4 | down | 0.53 | 0.29 |
P16070 | CD44 antigen | 0.06 | 4 | 3 | down | 0.96 | 0.91 |
Q16769 | Glutaminyl-peptide cyclotransferase | < 0.01 | 6 | 3 | down | 0.51 | 0.2 |
Q9BY67 | Cell adhesion molecule 1 | < 0.01 | 5 | 4 | down | 0.51 | 0.2 |
Spectral counts of urinary glycoproteins with significantly differential abundance (FDR-value < 0.1).
The candidate must exist in more than half of the non-cancer or cancer samples to qualify as a potential marker.